Endoscope Detergents And Disinfectants Market

Endoscope Detergents And Disinfectants Market Size, Market Forecast and Outlook By FMI

The endoscope detergents and disinfectants market was valued at USD 782.30 million in 2025, projected to reach USD 816.72 million in 2026, and is forecast to expand to USD 1.26 billion by 2036 at a 4.4% CAGR. As per FMI, rising endoscopic procedure volumes across gastroenterology, pulmonology, and urology departments, combined with tightening reprocessing compliance mandates from infection control accreditation bodies, are sustaining demand for validated cleaning and high-level disinfection chemistries. Endoscope reprocessing failures remain a leading cause of healthcare-associated infection outbreaks linked to contaminated duodenoscopes, creating non-discretionary procurement demand for detergents and disinfectants that meet validated efficacy thresholds against biofilm-forming organisms.

Summary of Endoscope Detergents And Disinfectants Market

• Market snapshot
  • The endoscope detergents and disinfectants market is valued at USD 782.30 million in 2025 and is projected to reach USD 1.26 billion by 2036.
  • The industry is expected to grow at a 4.4% CAGR from 2026 to 2036, creating an incremental opportunity of USD 439.55 million.
  • The market is a regulated healthcare consumable category where infection control accreditation mandates, endoscope reprocessing guidelines, and high-level disinfection efficacy requirements define procurement patterns.
• Demand and growth drivers
  • Demand is sustained by rising endoscopic procedure volumes across gastroenterology, pulmonology, and urology, each requiring validated reprocessing between patient uses.
  • Infection control accreditation bodies mandate high-level disinfection for all semi-critical endoscopes, creating non-discretionary consumable procurement requirements.
  • Enzymatic multi-enzyme detergent formulations are gaining share due to superior biofilm disruption and narrow-lumen cleaning efficacy in complex endoscope architectures.
  • Among key countries, China leads at 5.9% CAGR, followed by India at 5.5%, Germany at 5.1%, France at 4.6%, the UK at 4.2%, and the USA at 3.7%.
• Product and segment view
  • Endoscope detergents and disinfectants are validated reprocessing chemistries used to clean and disinfect flexible and rigid endoscopes between patient procedures.
  • Chemical properties include acidic, neutral, alkaline, and enzymatic formulations; potency levels include low-level, medium-level, and high-level disinfectants.
  • Neutral leads by Chemical Properties with 34.0% share in 2026, compatible with the widest range of endoscope materials and automated reprocessor systems.
  • High-Level Disinfectants leads by Potency with 48.0% share in 2026 as regulatory guidelines mandate HLD processing for all semi-critical endoscopes.
  • Scope includes endoscope cleaning detergents and disinfectant solutions; excludes sterilisation equipment, automated endoscope reprocessors, and single-use endoscope accessories.
• Geography and competitive outlook
  • China and India are the fastest-growing markets due to endoscopy suite expansion and hospital accreditation compliance adoption. The USA and Germany anchor mature, guideline-compliance-driven consumable demand.
  • Competition is shaped by validated efficacy documentation, AER system compatibility, and biofilm disruption performance.
  • Key players include MEDIVATORS Inc., STERIS plc, Borer Chemie AG, Cantel Medical, Getinge AB, Olympus Corporation, Vesimin Health, MDD Company GmbH, Georg Pauldrach, SIRMAXO CHEMICALS PVT. LTD, and Serim Research Corporation.
• Analyst opinion at FMI
  • Sabyasachi Ghosh, Principal Consultant for Healthcare and Infection Control, opines: 'As per FMI, endoscope reprocessing chemical procurement operates under a zero-tolerance compliance framework where substitution of validated chemistries with unqualified alternatives creates direct patient safety liability. Hospitals that standardise on enzymatic pre-cleaning detergents combined with FDA-cleared high-level disinfectants achieve the most consistent reprocessing audit outcomes. Chemistry suppliers without AER compatibility certifications across the installed base of major reprocessor brands face declining hospital formulary inclusion as sterile processing departments consolidate approved product lists to reduce validation burden.'
• Strategic implications / Executive takeaways
  • Sterile processing directors must standardise endoscope reprocessing chemical formularies on validated detergent-disinfectant combinations with documented AER compatibility across the facility's installed reprocessor base.
  • Infection control officers should specify enzymatic multi-enzyme pre-cleaning detergents for complex endoscope architectures with narrow lumens to reduce biofilm-associated reprocessing failure risk.
  • Procurement teams must evaluate chemistry suppliers on validated efficacy data breadth, AER compatibility certification coverage, and shelf-life stability under hospital storage conditions.

Endoscope Detergents And Disinfectants Market key takeaways

Metric	Details
Industry Size (2026)	USD 816.72 million
Industry Value (2036)	USD 1.26 billion
CAGR (2026 to 2036)	4.4%

Source: Future Market Insights, 2026

FMI opines that the high-level disinfectant (HLD) segment commands the largest potency share because regulatory guidelines from the FDA, European Medicines Agency, and national health authorities mandate HLD processing for all semi-critical endoscopes that contact mucous membranes. Enzymatic detergents are the fastest-growing chemistry type as multi-enzyme formulations demonstrate superior biofilm disruption and channel cleaning efficacy in complex endoscope architectures with narrow lumens. The shift from manual reprocessing to automated endoscope reprocessor (AER) systems is standardising detergent and disinfectant consumption per cycle, creating predictable per-procedure consumable demand that procurement teams can budget with unit-level accuracy.

China leads with a 5.9% CAGR through 2036 as hospital endoscopy suite expansion and updated infection control standards increase reprocessing chemical consumption. India follows at 5.5%, driven by growing gastroenterology procedure volumes and hospital accreditation compliance requirements under NABH standards. Germany registers a 5.1% pace as EU Medical Device Regulation reprocessing validation requirements tighten. France expands at 4.6% on the back of HAS accreditation endoscope hygiene audit requirements. The United Kingdom maintains a 4.2% trajectory driven by NHS decontamination standards and CQC inspection compliance. The United States tracks at 3.7%, reflecting mature FDA-cleared HLD consumption with incremental growth from single-use endoscope accessories reducing but not eliminating reprocessing volumes.

Endoscope Detergents And Disinfectants Market definition

Endoscope detergents and disinfectants are validated reprocessing chemistries used in the cleaning and high-level disinfection of flexible and rigid endoscopes between patient procedures. The category covers enzymatic pre-cleaning detergents, neutral pH cleaning solutions, and high-level disinfectant formulations (glutaraldehyde-based, ortho-phthalaldehyde, peracetic acid, hydrogen peroxide) used in manual and automated endoscope reprocessing workflows across hospital, diagnostic centre, and clinic settings.

Endoscope Detergents And Disinfectants Market inclusions

Market scope includes enzymatic and non-enzymatic endoscope cleaning detergents and high-level, medium-level, and low-level disinfectant solutions. The report covers global and regional market sizes for 2026 to 2036 with segment breakdowns by chemical properties, potency, and end user.

Endoscope Detergents And Disinfectants Market exclusions

The scope excludes automated endoscope reprocessor hardware, sterilisation equipment (autoclaves, ethylene oxide sterilisers), single-use endoscope accessories, and general-purpose hospital surface disinfectants not validated for endoscope reprocessing.

Endoscope Detergents And Disinfectants Market research methodology

• Primary research: Analysts engaged with sterile processing department managers, infection control officers, and endoscopy suite directors to map reprocessing chemical selection criteria and formulary standardisation decisions.
• Desk research: Data collection aggregated FDA 510(k) HLD clearance databases, SGNA reprocessing guidelines, EU MDR reprocessing validation requirements, and published endoscopic procedure volume statistics.
• Market sizing and forecasting: Baseline values derive from a bottom-up aggregation of reprocessing chemical consumption per endoscopic procedure, applying procedure volume growth curves and AER adoption penetration rates by geography.
• Data validation and update cycle: Projections are cross-validated against published infection control consumable company revenue disclosures and hospital procurement survey data from professional associations.

Identification of Restraining Elements in the Endoscope Detergents and Disinfectants Market

Although the expert analysts at FMI have revealed growth-propelling factors in the prevailing endoscope and disinfectants market, some aspects are also identified to inhibit the growth of the market. They are:

• The post-surgical adverse events and deaths associated with infected endoscopes have drastically impacted the market growth.
• The endoscopes of Olympus Medical have been recalled on a large scale due to events of death, and the company had to pay for the legal settlements with patients.
• Adequate cleaning, disinfection, and/or sterilization of endoscopes has been a challenge for hospital/clinical facilities despite the availability of recommended guidelines, which may impede the market growth.

The healthcare policies such as Medicaid and Medicare have kept the costs associated with Healthcare-associated Infections (HAIs), including SSIs, out of coverage. Hence, the patients have to pay it out of their pocket, which is a major factor restricting the growth of the market.

Regional Insights

Performance of North America Endoscope Detergents and Disinfectants Market

North America is currently dominating the market and is projected to account for a total of 35.1% market share of endoscopes and disinfectants during the forecast period.

The USA is a leading country in North America, which is surging the market by collecting huge revenue in recent years. In addition to this, the demand for safe and effective surgical procedures has been rising in the US over the last few years, with over 15 million endoscopy procedures performed annually. This is propelling the endoscope detergents and disinfectants market size in the coming years.

Inspect of European Endoscope Detergents and Disinfectants Market

Europe is projected to follow the North American region and hold a significant market share of 29.1% in the forum among all the regions during the forecast period.

Due to the rising numbers of healthcare infrastructure and the presence of rising patients and geriatric populations in the region, it is likely to impact the market in the long run for Europe. With increasing age, gastrointestinal (GI) related diseases increase. The endoscope is used in the diagnosis and treatment of GI-related diseases.

Brief Overview of Dominating Segments

Segment	QuaternaryAmmonium Compounds (By Type)
Market Share in Base Year	31.4%
Attributing Reasons	These compounds aid in controlling the spread of healthcare-associated infections in hospitals and clinics

Segment	Medical Device Disinfectant (By Product)
Market Share in Base Year	45.7%
Attributing Reasons	The increasing number of surgical procedures across the globe may be considered to be one of the major reasons for driving the segment over the forecast period.

Segment	Business to Business (By Sales Channel)
Market Share in Base Year	65.1%
Attributing Reasons	Medical device disinfectants, enzymatic cleaners, and surface disinfectants are major antiseptics and disinfectants highly marketed under the B2B sales channel.

Segment	Hospital (By End-Use)
Market Share in Base Year	46.2%
Attributing Reasons	The increasing incidence of hospital-acquired infections across the globe is one of the major reasons for segment growth over the forecast period.

Start-up Ecosystem

Start-ups Companies are Innovating in the Endoscope Detergents and Disinfectants Market

The technology in medicine is popped out by the various clinical and Research and Development institutions. Nowadays, start-up companies are interested in making unique devices to help patients throughout their treatment and recovery. This is likely to increase the opportunities in the endoscope detergents market in recent years.

Top Start-ups in the Endoscope Detergents and Disinfectants Market

Start-up Company	EnVision Endoscopy
Base Country and Year	USA-based Start-up, 206
Developments	The start-up provides various clinical surgeries with innovative and effective solutions. They are developing endoscopic surgery devices to help patients to recover their health with minimal expense. However, the company is developing a low-cost IGSS (Image Guided Suturing System) for managing gastrointestinal defects.

Start-up Company	MiWendo
Base Country and Year	Spain-based Start-up, 2026
Developments	The company is using microwave technology with a safe electromagnetic that is used to attach at conventional colonoscopy. Hence, it helps to detect polyps 360 Degrees and benign tissues

Competitive Landscape

Biggies Stirring Up the Soup in the Endoscope Detergents and Disinfectants Market

The key players are focusing on the product, which hits consumers desires. These players are adopting various methods to acquire a maximum share of the market, some of them are mergers, acquisitions, and product launches.

Recent Developments in the Endoscope Detergents and Disinfectants:

• In November 2024, the Environmental Protection Agency (EPA) of the USA approved 3M's disinfectant TB Quat for SARS-CoV-2, which is a ready-to-use cleaner. Third-party lab testing of 3M's disinfectant TB Quat ready-to-use cleaner on hard, non-porous surfaces with a 60-second contact period proved the disinfectant's effectiveness against the virus.
• January 2024, 5 SC Johnson home cleaning products have been added to Health Canada's list of effective disinfectants for use against SARS-CoV-2.

The newly adopted robotic systems were introduced in telesurgery in recent years. The first of this surgery is called the Lindbergh operation, which is a more effective and innovative surgery.

The Key Players in the global Endoscope Detergents and Disinfectants Market include

• MEDIVATORS Inc.
• STERIS plc
• Borer Chemie AG
• Cantel Medical
• Getinge AB
• Olympus Corporation
• Vesimin Health
• MDD Company GmbH
• Georg Pauldrach
• SIRMAXO CHEMICALS PVT.LTD
• Serim Research Corporation

Scope of the report

Metric	Value
Quantitative Units	USD 816.72 million to USD 1.26 billion, at a CAGR of 4.4%
Market Definition	Endoscope detergents and disinfectants are validated reprocessing chemistries for cleaning and high-level disinfection of flexible and rigid endoscopes between patient procedures.
Chemical Properties Segmentation	Acidic, Neutral, Alkaline, Enzymatic
Potency Segmentation	Low-Level Disinfectants, Medium-Level Disinfectants, High-Level Disinfectants
End User Segmentation	Hospitals, Diagnostic Centers, Clinics
Regions Covered	North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East & Africa
Countries Covered	China, India, Germany, France, UK, USA, and 40 plus countries
Key Companies Profiled	MEDIVATORS Inc., STERIS plc, Borer Chemie AG, Cantel Medical, Getinge AB, Olympus Corporation, Vesimin Health, MDD Company GmbH, Georg Pauldrach, SIRMAXO CHEMICALS PVT. LTD, Serim Research Corporation
Forecast Period	2026 to 2036
Approach	Bottom-up methodology starting with reprocessing chemical consumption per procedure, projecting procedure volume growth and AER adoption rates.

Key Segments in the Endoscope Detergents and Disinfectants Market

By Chemical Properties:

• Acidic
• Neutral
• Alkaline
• Enzymatic

By Potency:

• Low-Level Disinfectants
• Medium-Level Disinfectants
• High-Level Disinfectants

By End User:

• Hospitals
• Diagnostic Centers
• Clinics

By Region:

• North America
• Latin America
• Asia Pacific
• Middle East and Africa (MEA)
• Europe

Bibliography

• 1. United States Food and Drug Administration. (2024). Reprocessing of reusable medical devices: FDA guidance on high-level disinfection. FDA.
• 2. Society of Gastroenterology Nurses and Associates. (2024). Standards of infection prevention in the gastroenterology setting. SGNA.
• 3. European Commission. (2024). EU Medical Device Regulation 2017/745: Reprocessing validation requirements. European Commission.
• 4. World Health Organization. (2024). Decontamination and reprocessing of medical devices for healthcare facilities. WHO.
• 5. National Accreditation Board for Hospitals & Healthcare Providers, India. (2024). NABH accreditation standards: Endoscope reprocessing compliance requirements. NABH.
• 6. Organisation for Economic Co-operation and Development. (2024). Health at a Glance 2024: Endoscopic procedure volume indicators. OECD.

This bibliography is provided for reader reference. The full Future Market Insights report contains the complete reference list with primary research documentation.